Ambolodto, Zain S.
HRN: 26-30-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2024
CEFTRIAXONE 1G (VIAL)
11/30/2024
11/30/2024
IVT
285mg
Q12
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes